Emily Mackler

819 total citations
38 papers, 508 citations indexed

About

Emily Mackler is a scholar working on Family Practice, Economics and Econometrics and Oncology. According to data from OpenAlex, Emily Mackler has authored 38 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Family Practice, 16 papers in Economics and Econometrics and 15 papers in Oncology. Recurrent topics in Emily Mackler's work include Medication Adherence and Compliance (19 papers), Pharmaceutical Practices and Patient Outcomes (14 papers) and Economic and Financial Impacts of Cancer (10 papers). Emily Mackler is often cited by papers focused on Medication Adherence and Compliance (19 papers), Pharmaceutical Practices and Patient Outcomes (14 papers) and Economic and Financial Impacts of Cancer (10 papers). Emily Mackler collaborates with scholars based in United States and Egypt. Emily Mackler's co-authors include Karen B. Farris, Laura Petersen, E. J. King, James I. Ito, Judith E. Karp, Lindsey R. Baden, Eve M. Segal, Brahm H. Segal, John N. Greene and Michael G. Ison and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Emily Mackler

28 papers receiving 485 citations

Peers

Emily Mackler

ONCOL

EPIDE

Sue Kirsa Australia

Eric M. Tichy United States

Senthil Lingaratnam Australia

Janine Liefers Netherlands

Elvin A. Hernandez United States

Saurabh Chavan United States

Montserrat Tuset Spain

Richard J. Milne New Zealand

Brett Simchowitz United States

Christopher M. Dezii United States

Sue Kirsa Australia

Emily Mackler

175 ×0.8

ONCOL

115 ×0.8

EPIDE

37 ×0.3

175 ×1.5

63 ×0.8

Citations per year, relative to Emily Mackler Emily Mackler (= 1×) peers Sue Kirsa

Countries citing papers authored by Emily Mackler

Since Specialization

Citations

This map shows the geographic impact of Emily Mackler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Mackler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Mackler more than expected).

Fields of papers citing papers by Emily Mackler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Mackler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Mackler. The network helps show where Emily Mackler may publish in the future.

Co-authorship network of co-authors of Emily Mackler

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Mackler. A scholar is included among the top collaborators of Emily Mackler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Mackler. Emily Mackler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Muluneh, Benyam, Emily Mackler, Ashley Leak Bryant, et al.. (2025). Design and implementation of a risk-adapted, longitudinal, theory-driven medication adherence intervention: A protocol for a multi-phasic, hybrid effectiveness-implementation trial. Research in Social and Administrative Pharmacy. 21(6). 444–452. 1 indexed citations

Mackler, Emily, et al.. (2025). Assessing satisfaction for participants in a statewide cancer drug repository network.. JCO Oncology Practice. 21(10_suppl). 180–180.

Muluneh, Benyam, et al.. (2024). Key Performance Indicators and Metrics for the Implementation of an Oral Chemotherapy Adherence Program. Journal of the National Comprehensive Cancer Network. 22(3). 167–174.

Mackler, Emily, et al.. (2024). Statewide Cancer Drug Repository Reducing Waste in the Setting of Shortage Crisis. The Oncologist. 30(8). 1 indexed citations

Mackler, Emily, et al.. (2024). Influence of a community practice innovation on a statewide cancer drug repository network.. JCO Oncology Practice. 20(10_suppl). 115–115.

Salgado, Teresa M., Emily Mackler, William Irvin, et al.. (2024). Optimal hyperglycemia thresholds in patients undergoing chemotherapy: a cross sectional study of oncologists’ practices. Supportive Care in Cancer. 32(8). 563–563. 1 indexed citations

Gatwood, Justin, et al.. (2024). Managing medications for patients with cancer and chronic conditions: It's time for collaboration between primary care and oncology pharmacists. Journal of Oncology Pharmacy Practice. 31(1). 151–159.

Salgado, Teresa M., Emily Mackler, William Irvin, et al.. (2023). Oncologists’ responsibility, comfort, and knowledge managing hyperglycemia in patients with cancer undergoing chemotherapy: a cross sectional study. Supportive Care in Cancer. 31(8). 450–450. 1 indexed citations

Muluneh, Benyam, Emily Mackler, Ashley Leak Bryant, et al.. (2023). Barriers and facilitators associated with implementing interventions to support oral anticancer agent adherence in academic and community cancer center settings. PLoS ONE. 18(7). e0286630–e0286630. 1 indexed citations

10.

Manojlovich, Milisa, et al.. (2023). Video reflexive ethnography as an intervention to improve oral anti-cancer agent patient education: A pilot study. SHILAP Revista de lepidopterología. 2. 100148–100148.

11.

Gatwood, Justin, et al.. (2022). Medication Adherence Among Adults With Comorbid Chronic Conditions Initiating Oral Anticancer Agent Therapy for Multiple Myeloma. JCO Oncology Practice. 18(9). e1475–e1483. 3 indexed citations

12.

Mackler, Emily, et al.. (2022). Feasibility of a comprehensive medication review to improve medication use for patients with cancer and comorbid conditions. Supportive Care in Cancer. 30(12). 10111–10116. 6 indexed citations

13.

Stevenson, James G., et al.. (2018). Implementing a specialty pharmacy course within a professional pharmacy curriculum. Currents in Pharmacy Teaching and Learning. 11(1). 106–113. 2 indexed citations

14.

Salgado, Teresa M., et al.. (2017). The relationship between patient activation, confidence to self-manage side effects, and adherence to oral oncolytics: a pilot study with Michigan oncology practices. Supportive Care in Cancer. 25(6). 1797–1807. 38 indexed citations

15.

Mackler, Emily, Laura Petersen, Douglas W. Blayney, et al.. (2017). Implementing a Method for Evaluating Patient-Reported Outcomes Associated With Oral Oncolytic Therapy. Journal of Oncology Practice. 13(4). e395–e400. 13 indexed citations

16.

Mackler, Emily, et al.. (2015). Evaluation of outpatient medication reconciliation involving student pharmacists at a comprehensive cancer center. Journal of the American Pharmacists Association. 55(5). 540–545. 23 indexed citations

17.

Mackler, Emily, et al.. (2014). Association of high symptom burden with oral oncolytic agents.. Journal of Clinical Oncology. 32(31_suppl). 177–177. 1 indexed citations

18.

Mackler, Emily, et al.. (2012). Outcomes of therapy vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients. Supportive Care in Cancer. 20(9). 1935–1936. 4 indexed citations

19.

Johnson, Philip E., Rekha Garg, Scott Gottlieb, et al.. (2010). NCCN Oncology Risk Evaluation and Mitigation Strategies White Paper: Recommendations for Stakeholders. Journal of the National Comprehensive Cancer Network. 8(Suppl_7). S–7. 17 indexed citations

20.

Shehab, Nadine, et al.. (2007). Institutional Experience with Voriconazole Compared with Liposomal Amphotericin B as Empiric Therapy for Febrile Neutropenia. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(7). 970–979. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact